title: Bisphosphonate-induced osteonecrosis of the jaw.
abstract: Bisphosphonates are routinely used in the prevention and treatment of osteoporosis. Osteonecrosis of the jaw is known to be an important but rare complication of bisphosphonate usage. We present our experience with two patients of osteonecrosis of the jaw due to bisphosphonate usage.
authors: Department of Rheumatology, PD Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400016.
authors: Vishnu
authors: V
authors: Sharma
authors: S
authors: S
authors: Nagaraj
authors: Urmi
authors: U
authors: Choksey
authors: Ashit
authors: A
authors: Hegde
authors: Rohini
authors: R
authors: Samant
authors: C
authors: C
authors: Balakrishnan
mesh_terms: D000328:Adult; D000368:Aged; D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced* / Q000601:surgery / Q000628:therapy; D010020:Osteonecrosis / Q000139:chemically induced* / Q000601:surgery / Q000628:therapy; D010024:Osteoporosis / Q000188:drug therapy* / Q000517:prevention & control; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents; D019386:Alendronate